US

Won J Choi

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Won J Choi. Retrieved from https://idiyas.com/inventor/won-j-choi-urukgzze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Won J Choi: Innovator in Nucleoside Derivatives

Introduction

Won J Choi is a notable inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleoside derivatives. His work focuses on innovative therapeutic applications that address various medical conditions.

Latest Patents

Won J Choi holds a patent titled "Nucleoside Derivatives And Therapeutic Use Thereof." This invention relates to nucleoside derivatives represented by general formulas (I) and (II). It includes their synthetic methods and pharmacologically acceptable salts, as well as compositions containing such compounds. The patent also outlines methods for treating hyperproliferative disorders by administering these compounds.

Career Highlights

Choi is associated with Rexahn Corporation, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry. Despite having no patents listed under his name, his contributions to nucleoside derivatives are noteworthy.

Collaborations

Choi has collaborated with esteemed colleagues such as Chang H Ahn and Young Bok Lee. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

Won J Choi is a dedicated inventor whose work in nucleoside derivatives showcases his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the treatment of hyperproliferative disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…